PL3218351T3 - Sposób wytwarzania, wyodrębniania i oczyszczania farmaceutycznie dopuszczalnych postaci AHU-377 - Google Patents
Sposób wytwarzania, wyodrębniania i oczyszczania farmaceutycznie dopuszczalnych postaci AHU-377Info
- Publication number
- PL3218351T3 PL3218351T3 PL15808087T PL15808087T PL3218351T3 PL 3218351 T3 PL3218351 T3 PL 3218351T3 PL 15808087 T PL15808087 T PL 15808087T PL 15808087 T PL15808087 T PL 15808087T PL 3218351 T3 PL3218351 T3 PL 3218351T3
- Authority
- PL
- Poland
- Prior art keywords
- ahu
- isolation
- purification
- preparation
- pharmaceutically applicable
- Prior art date
Links
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
- C07C211/06—Monoamines containing only n- or iso-propyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
- C07C211/07—Monoamines containing one, two or three alkyl groups, each having the same number of carbon atoms in excess of three
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2014-792A CZ2014792A3 (cs) | 2014-11-14 | 2014-11-14 | Způsob přípravy, izolace a čištění farmaceuticky využitelných forem AHU-377 |
| CZ2015-758A CZ2015758A3 (cs) | 2015-10-27 | 2015-10-27 | Pevné formy vápenaté soli ethyl esteru (2R, 4S)-5-(bifenyl-4-yl)-4-[(3-karboxypropionyl)amino]-2-methylpentanové kyseliny, způsob jejich přípravy a použití |
| PCT/CZ2015/000136 WO2016074651A1 (en) | 2014-11-14 | 2015-11-11 | A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377 |
| EP15808087.9A EP3218351B1 (en) | 2014-11-14 | 2015-11-11 | A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3218351T3 true PL3218351T3 (pl) | 2019-12-31 |
Family
ID=54848362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15808087T PL3218351T3 (pl) | 2014-11-14 | 2015-11-11 | Sposób wytwarzania, wyodrębniania i oczyszczania farmaceutycznie dopuszczalnych postaci AHU-377 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3218351B1 (pl) |
| DK (1) | DK3218351T3 (pl) |
| ES (1) | ES2745157T3 (pl) |
| HU (1) | HUE046278T2 (pl) |
| LT (1) | LT3218351T (pl) |
| PL (1) | PL3218351T3 (pl) |
| PT (1) | PT3218351T (pl) |
| WO (1) | WO2016074651A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE052222T2 (hu) | 2015-07-02 | 2021-04-28 | Novartis Ag | Sacubitril kalciumsók |
| EP3386945A1 (en) * | 2015-12-11 | 2018-10-17 | Zentiva, K.S. | Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method |
| WO2018040065A1 (zh) * | 2016-09-02 | 2018-03-08 | 诺瑞特国际药业股份有限公司 | 缬沙坦二钠盐的晶型 |
| WO2018045505A1 (zh) * | 2016-09-07 | 2018-03-15 | 诺瑞特国际药业股份有限公司 | 沙库比曲钠盐新晶型 |
| CN106496055A (zh) * | 2016-10-09 | 2017-03-15 | 杭州科巢生物科技有限公司 | 一种抗心衰新药的关键组分沙库比曲的新合成方法 |
| WO2018069833A1 (en) * | 2016-10-10 | 2018-04-19 | Laurus Labs Limited | Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof |
| MX2019004992A (es) | 2016-10-28 | 2020-02-26 | Biocon Ltd | Sacubitril valsartán trisódico amorfo y proceso para su preparacion. |
| CN107188817A (zh) * | 2017-05-22 | 2017-09-22 | 杭州瑞法康科技有限公司 | 一种高纯度沙库比曲半钙盐一水合物的新晶型及其制备方法 |
| CN107602410A (zh) * | 2017-09-13 | 2018-01-19 | 浙江三门恒康制药有限公司 | 沙库比曲钠盐的晶型ii及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5217996A (en) | 1992-01-22 | 1993-06-08 | Ciba-Geigy Corporation | Biaryl substituted 4-amino-butyric acid amides |
| EP1467728B1 (en) | 2002-01-17 | 2007-08-22 | Novartis AG | Pharmaceutical compositions comprising valsartan and nep inhibitors |
| AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
| EP1903027A1 (en) | 2006-09-13 | 2008-03-26 | Novartis AG | Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors |
| DK2121578T3 (en) | 2007-01-12 | 2016-12-05 | Novartis Ag | A process for the preparation of 4-biphenyl-4-amino-2-methylpentanoic acid |
| PE20091364A1 (es) | 2008-01-17 | 2009-10-13 | Novartis Ag | Proceso para la preparacion de inhibidores de nep |
| JP5600183B2 (ja) | 2010-01-22 | 2014-10-01 | ノバルティス アーゲー | 中性エンドペプチダーゼ阻害剤の中間体およびその調製方法 |
| CA2806501A1 (en) | 2010-08-23 | 2012-03-01 | Novartis Ag | New process for the preparation of intermediates useful for the manufacture nep inhibitors |
| KR101476937B1 (ko) | 2010-08-23 | 2014-12-24 | 노파르티스 아게 | Ｎｅｐ 억제제의 제조를 위한 중간체의 제조 방법 |
| AR092278A1 (es) | 2012-08-31 | 2015-04-08 | Novartis Ag | Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados |
| CN105168205A (zh) * | 2015-08-18 | 2015-12-23 | 泰力特医药（湖北）有限公司 | 一种血管紧张素ii受体和脑啡肽酶受体双重抑制剂lcz696的制备方法 |
-
2015
- 2015-11-11 PL PL15808087T patent/PL3218351T3/pl unknown
- 2015-11-11 DK DK15808087.9T patent/DK3218351T3/da active
- 2015-11-11 LT LTEP15808087.9T patent/LT3218351T/lt unknown
- 2015-11-11 EP EP15808087.9A patent/EP3218351B1/en active Active
- 2015-11-11 ES ES15808087T patent/ES2745157T3/es active Active
- 2015-11-11 PT PT15808087T patent/PT3218351T/pt unknown
- 2015-11-11 HU HUE15808087A patent/HUE046278T2/hu unknown
- 2015-11-11 WO PCT/CZ2015/000136 patent/WO2016074651A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016074651A1 (en) | 2016-05-19 |
| HUE046278T2 (hu) | 2020-02-28 |
| DK3218351T3 (da) | 2019-09-16 |
| LT3218351T (lt) | 2019-09-25 |
| EP3218351B1 (en) | 2019-06-19 |
| ES2745157T3 (es) | 2020-02-27 |
| EP3218351A1 (en) | 2017-09-20 |
| PT3218351T (pt) | 2019-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201847T1 (hr) | Postupak za pripremu spoja diariltiohidantoina | |
| EP3096763A4 (en) | Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | |
| HUE046278T2 (hu) | Módszer AHU-377 gyógyszerészetben alkalmazható formáinak elõállítására, izolálására és tisztítására | |
| GB201418017D0 (en) | A system for, and method of, building a taxonomy | |
| ZA201706795B (en) | Process for the preparation of dicycloplatin | |
| IL277068B (en) | A cellular method for determining the potency of defibrotide | |
| GB201420259D0 (en) | A method of forming a beverage capsule, a beverage capsule and a beverage preparation system | |
| EP3227298A4 (en) | Process for the preparation of baricitinib and an intermediate thereof | |
| EP3201171A4 (en) | Method of preparing intermediate of salmeterol | |
| GB2561089B (en) | Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one | |
| IL250223B (en) | A method for the preparation of the pyrimidine-1-ol compound, and its intermediates | |
| IL247443B (en) | Process for the preparation of 5-fluorotryptophol | |
| EP3174878A4 (en) | A process for the preparation of palbociclib | |
| GB201420271D0 (en) | A method of forming a beverage capsule, a beverage capsule, a beverage preparation system and a set of tools | |
| HUE043822T2 (hu) | Eljárás glikolok elõállítására | |
| EP3221320A4 (en) | A process for the preparation of ibrutinib | |
| HK1258181A1 (zh) | 製備螯合劑的方法 | |
| SG10202111096SA (en) | Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract |